Chronic Pain Clinical Trial
Official title:
Use of Fentanyl Patch in Partial Doses Than the Original
Fentanyl is considered a potent synthetic opioid widely used in anesthesiology, for short
and long-term pain management, and for sedation. The fentanyl patch is constructed like a
matrix, a system based on a polyacrylate net with fentanyl that attaches directly onto the
skin. The doses available today are from 12µg/h, 25, 50, 75, to 100 µg/h. Despite the
variable doses available, often in certain patients as the elderly or children, there is a
need for slower titration than the 12 µg/h currently available.
In this study, the investigators aim to evaluate pain control and to examine the blood
fentanyl concentration of patients on a fix dose of fentanyl patch up to 100 µg/h every two
or three days, and compare it with pain control and concentration levels obtained from a
similar dose patch, but after cutting the patch into two.
The study will take place at the pain clinic of Clalit Health Services-South District
(CHS-SD), and the Negev home palliative care unit. In CHS-SD there are approximately 300
patients treated regularly with opioids and about 120 patients in the home palliative care
unit. A sample of 95 patients will be recruited. Once consent form is signed, blood samples
will be collected twice: 1. At the time of the visit; 2. After 144 hours (about 6 days) from
the first sample, and at least 36 hours after replacing the cut patch. Pain management will
be evaluated at both visits using the Brief Pain Inventory (Hebrew version) - BPI
questionnaire, and rescue doses used before and after the cutting of the patch. The blood
samples will be transferred to the laboratory for testing of fentanyl concentration levels.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|